John Hart to Carcinoma, Hepatocellular
This is a "connection" page, showing publications John Hart has written about Carcinoma, Hepatocellular.
Connection Strength
1.384
-
Laser microdissection for gene expression study of hepatocellular carcinomas arising in cirrhotic and non-cirrhotic livers. Methods Mol Biol. 2011; 755:233-44.
Score: 0.285
-
Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010 Aug; 34(8):1147-54.
Score: 0.277
-
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Mod Pathol. 2006 Apr; 19(4):533-40.
Score: 0.205
-
Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am J Surg Pathol. 2004 Mar; 28(3):357-64.
Score: 0.178
-
Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma. J Comput Assist Tomogr. 2016 May-Jun; 40(3):493-7.
Score: 0.103
-
The Pathology of Alcoholic Liver Disease. Clin Liver Dis. 2016 Aug; 20(3):473-89.
Score: 0.103
-
Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis. Histopathology. 2010 May; 56(6):683-93.
Score: 0.068
-
Recent developments in liver pathology. Arch Pathol Lab Med. 2009 Jul; 133(7):1078-86.
Score: 0.064
-
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. Mod Pathol. 2009 Aug; 22(8):1113-20.
Score: 0.064
-
Efficacy of computed tomography in detecting hepatocellular cancer in adult liver transplant candidates. Transplant Proc. 2001 Feb-Mar; 33(1-2):1854-5.
Score: 0.036